Compare CYTK & KVYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CYTK | KVYO |
|---|---|---|
| Founded | 1997 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 8.8B |
| IPO Year | 2004 | 2023 |
| Metric | CYTK | KVYO |
|---|---|---|
| Price | $64.13 | $25.86 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 16 | 23 |
| Target Price | ★ $82.38 | $43.00 |
| AVG Volume (30 Days) | 2.2M | ★ 3.1M |
| Earning Date | 02-26-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $87,211,000.00 | ★ $1,153,988,000.00 |
| Revenue This Year | $339.72 | $32.38 |
| Revenue Next Year | $79.08 | $21.60 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 2609.26 | 32.81 |
| 52 Week Low | $29.31 | $23.44 |
| 52 Week High | $70.98 | $49.55 |
| Indicator | CYTK | KVYO |
|---|---|---|
| Relative Strength Index (RSI) | 52.25 | 31.16 |
| Support Level | $60.30 | $27.26 |
| Resistance Level | $65.08 | $28.65 |
| Average True Range (ATR) | 2.78 | 1.35 |
| MACD | 0.14 | -0.64 |
| Stochastic Oscillator | 69.51 | 0.69 |
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
Klaviyo Inc is a technology company that provides a software-as-a-service (SaaS) platform to enable its customers to send the right messages at the right time across email, short message service, and push notifications, more accurately measure and predict performance, and deploy specific actions and campaigns. The platform combines proprietary data and application layers into one solution with machine learning and artificial intelligence capabilities. It is focused on marketing automation within eCommerce as its first application use case. It generates revenue through the sale of subscriptions to its customers for the use of its platform. Geographically, the company generates the majority of its revenue from the Americas, followed by EMEA and APAC.